NEW YORK (GenomeWeb) – Insilico Medicine said this week that it will integrate unspecified data assets as well as the staff of InSilico Screen, a Belgian bioinformatics company that provides tools for dynamic signaling modelling and scalable molecular simulations.

Under the terms of the agreement, InSilico Screen Founder and CEO Quentin Vanhaelen will join Insilico Medicine as the head of the so-called "almost human" team. He will split his time between Baltimore, where InSilico Medicine has an office, and Brussels, where InSilico Screen is located.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.